1. Home
  2. GH vs CCK Comparison

GH vs CCK Comparison

Compare GH & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$85.12

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Logo Crown Holdings Inc.

CCK

Crown Holdings Inc.

HOLD

Current Price

$98.78

Market Cap

11.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
CCK
Founded
2011
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Containers/Packaging
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
11.4B
IPO Year
2018
2003

Fundamental Metrics

Financial Performance
Metric
GH
CCK
Price
$85.12
$98.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
20
15
Target Price
$117.80
$123.27
AVG Volume (30 Days)
1.7M
840.1K
Earning Date
04-29-2026
04-27-2026
Dividend Yield
N/A
1.03%
EPS Growth
6.74
79.72
EPS
N/A
6.38
Revenue
$982,021,000.00
$11,665,000,000.00
Revenue This Year
$33.40
$5.26
Revenue Next Year
$28.55
$2.40
P/E Ratio
N/A
$15.81
Revenue Growth
32.88
N/A
52 Week Low
$36.36
$75.98
52 Week High
$120.74
$116.62

Technical Indicators

Market Signals
Indicator
GH
CCK
Relative Strength Index (RSI) 34.90 27.38
Support Level $82.26 $94.24
Resistance Level $103.16 $98.83
Average True Range (ATR) 3.94 2.41
MACD 0.07 -1.16
Stochastic Oscillator 20.02 3.33

Price Performance

Historical Comparison
GH
CCK

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About CCK Crown Holdings Inc.

Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

Share on Social Networks: